Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction
Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to show that low dose recombinant BNP coupled with
phosphodiesterase V inhibition will improve renal dysfunction and promote relief of volume
overload in patinets with acute decompensated heart failure complicated by the cardiorenal
syndrome.